AU3002384A - Etofenamate formulations - Google Patents

Etofenamate formulations

Info

Publication number
AU3002384A
AU3002384A AU30023/84A AU3002384A AU3002384A AU 3002384 A AU3002384 A AU 3002384A AU 30023/84 A AU30023/84 A AU 30023/84A AU 3002384 A AU3002384 A AU 3002384A AU 3002384 A AU3002384 A AU 3002384A
Authority
AU
Australia
Prior art keywords
etofenamate
formulations
weight
isopropyl myristate
cream formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU30023/84A
Other versions
AU563760B2 (en
Inventor
Hans-Dieter Dell
Reinhold Kraus
Detlef Schierstedt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Publication of AU3002384A publication Critical patent/AU3002384A/en
Application granted granted Critical
Publication of AU563760B2 publication Critical patent/AU563760B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Color Television Image Signal Generators (AREA)
  • Stereophonic System (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Fats And Perfumes (AREA)

Abstract

1. Cream formulation for etofenamate, characterized in that it contains 5 to 80% by weight of isopropyl myristate and 2 to 30% by weight of etofenamate.
AU30023/84A 1983-07-01 1984-06-29 Etofenamate formulations Ceased AU563760B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833323832 DE3323832A1 (en) 1983-07-01 1983-07-01 OVEN AMATE PREPARATION
DE3323832 1983-07-01

Publications (2)

Publication Number Publication Date
AU3002384A true AU3002384A (en) 1985-01-03
AU563760B2 AU563760B2 (en) 1987-07-23

Family

ID=6202950

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30023/84A Ceased AU563760B2 (en) 1983-07-01 1984-06-29 Etofenamate formulations

Country Status (8)

Country Link
EP (1) EP0130516B1 (en)
JP (1) JPS6025921A (en)
KR (1) KR920006905B1 (en)
AT (1) ATE56867T1 (en)
AU (1) AU563760B2 (en)
DE (2) DE3323832A1 (en)
FI (1) FI842612A (en)
NZ (1) NZ208693A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011036A1 (en) * 1990-12-21 1992-07-09 Wade, Jonathan, Leslie Adjuvants containing unsaturated lipid

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810387A (en) * 1985-09-28 1989-03-07 Kleentek Industrial Co., Ltd. Method for removing water soluble substances in non-water-soluble fluid
US4738842A (en) * 1986-01-17 1988-04-19 Riker Laboratories Topical antiinflammatory compositions
DE3632359A1 (en) * 1986-09-24 1988-04-07 Troponwerke Gmbh & Co Kg PREPARATIONS FOR MEDICINAL PRODUCTS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
DE3045913A1 (en) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011036A1 (en) * 1990-12-21 1992-07-09 Wade, Jonathan, Leslie Adjuvants containing unsaturated lipid

Also Published As

Publication number Publication date
FI842612A0 (en) 1984-06-28
ATE56867T1 (en) 1990-10-15
EP0130516B1 (en) 1990-09-26
AU563760B2 (en) 1987-07-23
KR920006905B1 (en) 1992-08-22
KR850000970A (en) 1985-03-14
EP0130516A3 (en) 1986-07-30
DE3323832A1 (en) 1985-01-03
NZ208693A (en) 1986-11-12
DE3483285D1 (en) 1990-10-31
JPS6025921A (en) 1985-02-08
FI842612A (en) 1985-01-02
EP0130516A2 (en) 1985-01-09

Similar Documents

Publication Publication Date Title
AU583568B2 (en) Improved pharmaceutical composition containing 13-cis vitamin A acid as the active ingredient
HUT41221A (en) Insecticide and acaricide compositions further process for preparing phenoxy-alkyl-amino-pyridine derivatives as active ingredients thereof
HUT44135A (en) Herbicide compositions containing triazol-sulfonamide derivatives as active components and process for producing the active components
AU5354286A (en) Pyrethroidal composition comprising more than one active ingredients
GR3007385T3 (en)
HUT41957A (en) Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents
HUT41600A (en) Herbicide and fungicide compositions containing sulphonamide derivatives as active substances further process for preparing the active ingredients
HUT41605A (en) Insecticide compositions containing piridazinone derivatives as active ingredients and process for preparing the active substances
HUT41213A (en) Pesticide compositions containing benzodioxole derivatives as active ingredients and process for preparing the active compounds
HUT39569A (en) Pesticide compositions containing 13beta-milbemycin derivatives and process for preparing the active ingredients
HUT44130A (en) Herbicide compositions containing thiazolo-triazol-sulfonamide derivatives as active components and process for producing the active components
HUT44134A (en) Herbicide compositions containing triazolo-sulfonamide derivatives as active components and process for producing the active components
HUT41206A (en) Fungicide compositions containing alpha-oximino-alpha-carbamoyl-acetonitril derivatives as active agents and process for producing the active agents
HUT41216A (en) Fungicide compositions containing derivatives of alpha-pyridyl-beta-phenyl-alkanols as active ingredients and process for preparing the active substances
HUT39962A (en) Herbicide compositions containing 2,4-diamino-pyrimidine derivatives as active ingredients and process for preparing the active ingredients
AU563760B2 (en) Etofenamate formulations
HUT42269A (en) Herbicide and fungicide compositions containing carbamoyl-imidazol derivatives as active agents and process for producing carbamoyl-imidazol derivatives
HU903052D0 (en) Herbicide compositions containing substituted thieno- and furo-imidazo-pyrrolo-pyridin-dione derivatives as active ingredient
HUT44011A (en) Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
HUT41764A (en) Herbicide compositions containing 5-amino-4-cyano-1-pyridyl-pyrazole derivatives as active agents and process for producing the active agents
HUT44129A (en) Herbicide compositions containing 1-aryl-pyrazol derivatives as active components and process for producing 1-aryl-pyrazol derivatives
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
HUT41961A (en) Herbicide compositions containing thienyl-sulfonyl-guanidine derivatives as active agents and process for producing the active agents
HUT41225A (en) Insectide and acaricide compositions containing 1,3-diphenyl-1,2,4-triazole derivatives as active substances and process for preparing the active substances
HUT38353A (en) Process for producing 7-oxo-4-thia-1-azabicyclo/3.2.0/hept-2-ene derivatives and pharmaceutical compositions containing them as active agents

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired